Very low-intensity antithrombotic therapy in atrial fibrillation.
Koefoed
B G
BG
Danish National Board of Health, Copenhagen, Denmark.
Petersen
P
P
D001241:Aspirin / Q000008:administration & dosage / Q000009:adverse effects; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy*; D002561:Cerebrovascular Disorders / Q000209:etiology / Q000517:prevention & control; D002986:Clinical Trials as Topic; D005343:Fibrinolytic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D014859:Warfarin / Q000008:administration & dosage / Q000009:adverse effects
D005343:Fibrinolytic Agents; D014859:Warfarin; D001241:Aspirin